Skip to main content

Month: August 2025

Vaso Corporation Announces Financial Results for Second Quarter of 2025

PLAINVIEW, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, today announced operating results for the three months ended June 30, 2025. “The Company’s 2025 second quarter revenue was $20.0 million, slightly down from $20.2 million for the same quarter of the prior year,” commented Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “The decrease in revenue was primarily in the professional sales service segment as a result of lower equipment delivery volume by our partner. The value of orders we booked in this business segment, however, continued to outpace delivery of the underlying equipment, as reflected in higher...

Continue reading

Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

– Live video webcast on Wednesday, August 20th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details of the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:00 PM ET Presenter: Walter Klemp, Founder, President, CEO and Chairman of Moleculin Registration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost...

Continue reading

Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Tuesday, August 19th at 2:00 PM ET BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads for the treatment of cancer, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Tuesday, August 19, 2025 at 2:00 PM ET Presenter: Abizer Gaslightwala, President and Chief Executive Officer of AkariRegistration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a...

Continue reading

Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Tuesday, August 19th at 2:20 PM ET SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date/Time: Tuesday, August 19, 2025 at 2:20 PM ET Presenter: Timothy Lu, M.D., Ph.D., Senti Bio’s Co-Founder and Chief Executive OfficerRegistration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology....

Continue reading

AAGC Set to Launch New Concept

LAS VEGAS, Aug. 14, 2025 (GLOBE NEWSWIRE) — All American Gold Corp. (OTC: AAGC) is delighted to update the public about the Company’s exciting new concept in the Beauty industry. Hollywood Star Cuts (A Family Salon) and All American Gold Corp. (AAGC) have finalized an agreement with a Franchise group based in San Diego, CA, to launch a concept that will complement the proven Hollywood Star Cuts model in exclusive areas. Hollywood Star Salons is an exciting new platform set to debut in October 2025 in Encinitas, California. Construction is scheduled to begin on September 1, 2025. Hollywood Star Salons will be servicing a much more exclusive and demanding clientele with much more private and demanding requirements. Hollywood Star Salons will be an Owner Operator based model designed to alloy the individual stylist the freedom to...

Continue reading

Jet.AI Inc. Announces Strategic Capital Contribution to AIIA Sponsor Ltd., the Sponsor of a SPAC Organized to Pursue AI, Machine Learning, and Data Center Operations

LAS VEGAS, Aug. 14, 2025 (GLOBE NEWSWIRE) — Jet.AI Inc. ( “Jet.AI” or the “Company”) (Nasdaq: JTAI), a provider of high-performance GPU infrastructure and AI cloud services, today announced it has made a capital contribution to AIIA Sponsor Ltd. (“Sponsor”) which serves as the sponsor of AI Infrastructure Acquisition Corp., a special purpose acquisition company. On August 13, 2025, AI Infrastructure Acquisition Corp. filed a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in connection with a proposed initial public offering of its units. AI Infrastructure Acquisition Corp. intends to conduct an initial public offering and then focus on transaction opportunities with high-impact private technology companies advancing artificial intelligence...

Continue reading

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ETPresenter: Marc Hertz, PhD, President, Chief Executive Officer and DirectorRegistration Link: HERE About Webull Financial  Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology....

Continue reading

Wrap Technologies Unveils Second Counter-UAS Program: Handheld Surface-To-Air, Quick-Reaction Personal Anti-Drone Capability Repurposing BolaWrap 150

Wrap PAN-DA launches Kevlar tethers from existing BolaWrap 150 product line designed to physically entangle and disable hostile drones midair—deepens offerings into DoD and estimated $6.8B global counter-UAS market MIAMI, Aug. 14, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company” or “Wrap”), a global leader in innovative public safety technology, today announced its second research and development counter-unmanned aircraft systems (C-UAS) initiative and released a Phase One video showing proof of concept on its website (www.Wrap.com). Wrap’s Project PAN-DA (Personal Anti-Drone Armament) concept is a handheld counter-drone system derived from the Company’s proven BolaWrap® 150 platform. This first-phase milestone follows Wrap’s recent entry into the C-UAS market and introduces a personal, close-range,...

Continue reading

VERSES® Unveils Robotics Architecture that Works Without Pre-Training

VERSES multi-agent robotics model show to outperform current methods on Meta’s Habitat Benchmark without pre-training VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, today unveiled details on the development of its robotics model. The VERSES robotics architecture accomplished typical household tasks of tidying the room, preparing the groceries, and setting the table, better than other robotics models and VERSES accomplished the tasks without any pre-training. A video of the robot performing these tasks can be seen on the VERSES website https://www.verses.ai/blog. Robots often perform well on scripted tasks but can freeze when faced with new situations;...

Continue reading

North Media upgrades its full-year EBITDA and EBIT guidance based on preliminary financial results for the second quarter of 2025.

Company Announcement no. 10-202514 August 2025Revenue for Q2 2025 was DKK 342m against DKK 343m in the year-earlier period. Last Mile saw a largely flat trend, with the expected decline in FK Distribution being outweighed by SDR having taken over local sales from former franchise partners. Digital Services improved by 2%, primarily driven by BoligPortal. EBITDA was DKK 48m against DKK 61m in Q2 2024, and EBIT was DKK 32m against DKK 44m in the year-earlier period. North Media expects its full-year revenue for 2025 to be in the DKK 1,270–1,315m range (previously DKK 1,280–1,337m), for EBITDA of DKK 105–130m (previously DKK 80–115m) and EBIT of DKK 50–75m (previously DKK 25–60m). The EBITDA and EBIT upgrade is mainly attributable to improved operations at SDR. The Group is now seeing the initial effects of the distribution model transition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.